Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Oral Food Challenge Trial of Xolair (Omalizumab) in Peanut Allergy

NCT00086606 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00086606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00086606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Oral Food Challenge Trial of Xolair (Omalizumab) in Peanut Allergy
Lead sponsor
Genentech, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2004
Completion date
April 30, 2006
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergy